Healthcare provider profile · identity verified

Bevan Ali Geslani, M.D.

Internal Medicine · LOMA LINDA, CA · NPI 1992741862

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	873	337
Amlodipine Besylate	Amlodipine Besylate	594	215
Losartan Potassium	Losartan Potassium	378	166
Lisinopril	Lisinopril	361	139
Levothyroxine Sodium	Levothyroxine Sodium	333	129
Gabapentin	Gabapentin	319	114
Metformin Hcl	Metformin Hcl	297	126
Rosuvastatin Calcium	Rosuvastatin Calcium	262	118
Omeprazole	Omeprazole	259	104
Trazodone Hcl	Trazodone Hcl	255	81
Hydrochlorothiazide	Hydrochlorothiazide	246	100
Pantoprazole Sodium	Pantoprazole Sodium	227	95
Metoprolol Succinate	Metoprolol Succinate	215	82
Tamsulosin Hcl	Tamsulosin Hcl	192	76
Meloxicam	Meloxicam	148	53
Metformin Hcl Er	Metformin Hcl	138	54
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	136	43
Ozempic	Semaglutide	126	38
Furosemide	Furosemide	114	52
Eliquis	Apixaban	113	39
Mounjaro	Tirzepatide	113	23
Triamcinolone Acetonide	Triamcinolone Acetonide	113	73
Albuterol Sulfate Hfa	Albuterol Sulfate	111	64
Carvedilol	Carvedilol	110	47
Fluticasone Propionate	Fluticasone Propionate	107	57
Sertraline Hcl	Sertraline Hcl	107	41
Simvastatin	Simvastatin	104	39
Allopurinol	Allopurinol	94	39
Glipizide Er	Glipizide	94	35
Ibuprofen	Ibuprofen	93	49
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	91	37
Methocarbamol	Methocarbamol	91	46
Zolpidem Tartrate	Zolpidem Tartrate	88	23
Diclofenac Sodium	Diclofenac Sodium	87	45
Benazepril Hcl	Benazepril Hcl	84	34
Alprazolam	Alprazolam	82	21
Duloxetine Hcl	Duloxetine Hcl	82	28
Metoprolol Tartrate	Metoprolol Tartrate	82	38
Famotidine	Famotidine	78	39
Atenolol	Atenolol	77	28
Finasteride	Finasteride	77	30
Januvia	Sitagliptin Phosphate	73	16
Glipizide	Glipizide	72	32
Sildenafil Citrate	Sildenafil Citrate	69	19
Mirtazapine	Mirtazapine	67	20
Tramadol Hcl	Tramadol Hcl	67	23
Hydroxyzine Hcl	Hydroxyzine Hcl	66	26
Bupropion Xl	Bupropion Hcl	65	19
Potassium Chloride	Potassium Chloride	65	24
Alendronate Sodium	Alendronate Sodium	64	24
Chlorthalidone	Chlorthalidone	63	27
Clopidogrel	Clopidogrel Bisulfate	63	29
Escitalopram Oxalate	Escitalopram Oxalate	57	18
Donepezil Hcl	Donepezil Hcl	56	15
Lorazepam	Lorazepam	55	17
Prednisone	Prednisone	54	36
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	53	22
Azithromycin	Azithromycin	52	46
Pravastatin Sodium	Pravastatin Sodium	51	24
Trulicity	Dulaglutide	50	14
Pregabalin	Pregabalin	48	16
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	46	20
Glimepiride	Glimepiride	45	17
Ezetimibe	Ezetimibe	44	12
Montelukast Sodium	Montelukast Sodium	44	25
Citalopram Hbr	Citalopram Hydrobromide	43	15
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	43	20
Gavilyte-G	Peg3350/Sod Sulf,bicarb,cl/Kcl	42	42
Baclofen	Baclofen	37	17
Loperamide	Loperamide Hcl	37	suppressed
Hydralazine Hcl	Hydralazine Hcl	36	14
Meclizine Hcl	Meclizine Hcl	36	17
Folic Acid	Folic Acid	35	11
Spironolactone	Spironolactone	35	15
Sumatriptan Succinate	Sumatriptan Succinate	34	suppressed
Acyclovir	Acyclovir	33	14
Nitroglycerin	Nitroglycerin	33	24
Clonidine Hcl	Clonidine Hcl	32	11
Esomeprazole Magnesium	Esomeprazole Magnesium	32	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	32	27
Amitriptyline Hcl	Amitriptyline Hcl	31	13
Lovastatin	Lovastatin	31	12
Nifedipine Er	Nifedipine	31	18
Fluoxetine Hcl	Fluoxetine Hcl	30	suppressed
Lactulose	Lactulose	30	15
Levetiracetam	Levetiracetam	30	suppressed
Peg-3350 And Electrolytes	Peg3350/Sod Sulf,bicarb,cl/Kcl	30	30
Warfarin Sodium	Warfarin Sodium	30	suppressed
Ciclopirox	Ciclopirox	29	15
Ondansetron Hcl	Ondansetron Hcl	29	17
Ventolin Hfa	Albuterol Sulfate	29	12
Farxiga	Dapagliflozin Propanediol	28	suppressed
Symbicort	Budesonide/Formoterol Fumarate	28	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	27	suppressed
Azelastine Hcl	Azelastine Hcl	26	12
Clobetasol Propionate	Clobetasol Propionate	26	suppressed
Colchicine	Colchicine	26	14
Dicyclomine Hcl	Dicyclomine Hcl	26	17
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	25	13
Diazepam	Diazepam	25	suppressed
Xarelto	Rivaroxaban	25	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	24	suppressed
Tizanidine Hcl	Tizanidine Hcl	24	suppressed
Latanoprost	Latanoprost	23	suppressed
Naproxen	Naproxen	23	14
Pioglitazone Hcl	Pioglitazone Hcl	23	suppressed
Lidocaine	Lidocaine	22	15
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	22	19
Synthroid	Levothyroxine Sodium	22	suppressed
Amoxicillin	Amoxicillin	21	14
Buspirone Hcl	Buspirone Hcl	21	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	21	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	21	suppressed
Jardiance	Empagliflozin	21	suppressed
Ondansetron Odt	Ondansetron	21	11
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	21	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	21	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	20	20
Valsartan	Valsartan	20	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	19	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	19	suppressed
Paroxetine Hcl	Paroxetine Hcl	19	suppressed
Ropinirole Hcl	Ropinirole Hcl	19	suppressed
Amlodipine-Olmesartan	Amlodipine Bes/Olmesartan Med	18	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	18	suppressed
Calcitriol	Calcitriol	18	suppressed
Humalog Kwikpen U-100	Insulin Lispro	18	12
Irbesartan	Irbesartan	18	suppressed
Labetalol Hcl	Labetalol Hcl	18	suppressed
Cephalexin	Cephalexin	17	16
Dutasteride	Dutasteride	17	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	17	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	17	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	16	16
Estradiol	Estradiol	16	suppressed
Fluconazole	Fluconazole	16	12
Ketoconazole	Ketoconazole	16	suppressed
Lamotrigine	Lamotrigine	16	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	16	suppressed
Procto-Med Hc	Hydrocortisone	16	suppressed
Risperidone	Risperidone	16	suppressed
Humulin N Kwikpen	Insulin Nph Human Isophane	15	suppressed
Oxycodone Hcl	Oxycodone Hcl	15	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	14	13
Aripiprazole	Aripiprazole	14	suppressed
Phenobarbital	Phenobarbital	14	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	14	suppressed
Rybelsus	Semaglutide	14	suppressed
Sucralfate	Sucralfate	14	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	14	suppressed
Verapamil Er	Verapamil Hcl	14	suppressed
Celecoxib	Celecoxib	13	suppressed
Linzess	Linaclotide	13	suppressed
Myrbetriq	Mirabegron	13	suppressed
Terazosin Hcl	Terazosin Hcl	13	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	12	suppressed
Divalproex Sodium	Divalproex Sodium	12	suppressed
Methotrexate	Methotrexate Sodium	12	suppressed
Mometasone Furoate	Mometasone Furoate	12	suppressed
Doxepin Hcl	Doxepin Hcl	11	suppressed
Enalapril Maleate	Enalapril Maleate	11	suppressed
Fluocinonide	Fluocinonide	11	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	11	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	11	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error